Gynecologic and Obstetric Investigation
Case Report
Relationship between Abnormally High Levels of Plasma CA 125 and Resolution of Acute Pelvic Pain in Two Women with EndometriomaGuerriero S. · Ajossa S. · Cafflero A. · Mais V.Department of Obstetrics and Gynecology of the University of Cagliari, Italy
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: October 17, 1994
Accepted: December 22, 1994
Published online: March 01, 2010
Issue release date: 1995
Number of Print Pages: 3
Number of Figures: 0
Number of Tables: 0
ISSN: 0378-7346 (Print)
eISSN: 1423-002X (Online)
For additional information: https://www.karger.com/GOI
Abstract
Two premenopausal women presented with endometrioma and slightly elevated CA 125 plasma levels (42.5 and 39.0 U/ml). After initial evaluation, both patients had an episode of sudden onset of pelvic pain with rapid resolution after a few hours. During the pain episode, CA 125 plasma levels were similar to the initial evaluation (41.7 and 40.3 U/ml), while 12 h after resolution of the pain, very high levels were measured in both patients (630 and 575 U/ml). The absence of tubal abnormalities and the negative peritoneal fluid cultural evaluation demonstrated by laparoscopy suggested a retrospective clinical diagnosis of partial ovarian torsion with sudden spontaneous untwisting. Therefore, an abnormal elevation of CA 125 plasma levels in patients with benign adnexal masses may be correlated with episodes of partial ovarian torsion with subsequent detorsion.
© 1995 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Received: October 17, 1994
Accepted: December 22, 1994
Published online: March 01, 2010
Issue release date: 1995
Number of Print Pages: 3
Number of Figures: 0
Number of Tables: 0
ISSN: 0378-7346 (Print)
eISSN: 1423-002X (Online)
For additional information: https://www.karger.com/GOI
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission